Literature DB >> 22692497

Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.

Grazia Andolfi1, Georgia Fousteri, Maura Rossetti, Chiara F Magnani, Tatiana Jofra, Grazia Locafaro, Attilio Bondanza, Silvia Gregori, Maria-Grazia Roncarolo.   

Abstract

Type 1 regulatory T (Tr1) cells are an inducible subset of CD4(+) Tr cells characterized by high levels of interleukin (IL)-10 production and regulatory properties. Several protocols to generate human Tr1 cells have been developed in vitro. However, the resulting population includes a significant fraction of contaminating non-Tr1 cells, representing a major bottleneck for clinical application of Tr1 cell therapy. We generated an homogeneous IL-10-producing Tr1 cell population by transducing human CD4(+) T cells with a bidirectional lentiviral vector (LV) encoding for human IL-10 and the marker gene, green fluorescent protein (GFP), which are independently coexpressed. The resulting GFP(+) LV-IL-10-transduced human CD4(+) T (CD4(LV-IL-10)) cells expressed, upon T-cell receptor (TCR) activation, high levels of IL-10 and concomitant low levels of IL-4, and markers associated with IL-10. Moreover, CD4(LV-IL-10) T cells displayed typical Tr1 features: the anergic phenotype, the IL-10, and transforming growth factor (TGF)-β dependent suppression of allogeneic T-cell responses, and the ability to suppress in a cell-to-cell contact independent manner in vitro. CD4(LV-IL-10) T cells were able to control xeno graft-versus-host disease (GvHD), demonstrating their suppressive function in vivo. These results show that constitutive over-expression of IL-10 in human CD4(+) T cells leads to a stable cell population that recapitulates the phenotype and function of Tr1 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692497      PMCID: PMC3437582          DOI: 10.1038/mt.2012.71

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  49 in total

1.  CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

Authors:  T Jinquan; S Quan; H H Jacobi; H O Madsen; C Glue; P S Skov; H J Malling; L K Poulsen
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  Allo-specific T-cells encoding for viral IL-10 exert strong immunomodulatory effects in vitro but fail to prevent graft rejection.

Authors:  Christine Brandt; Jun Yang; Isabella Schmitt-Knosalla; Anja Siepert; Markus H Hammer; Katrin Vogt; Birgit Sawitzki; Manfred Lehmann; Hans-Dieter Volk; Thomas Ritter
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

3.  [Antigen-specific T cells transduced with interleukin-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen].

Authors:  Y Misaki; K Setoguchi; Y Araki; K Fujio; K Kawahata; T Kitamura; K Yamamoto
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2000-12

4.  Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection.

Authors:  J Zhao; G J Pettigrew; E M Bolton; C R Murfitt; A Carmichael; J A Bradley; A M L Lever
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

Review 5.  Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

Authors:  Maria Grazia Roncarolo; Silvia Gregori; Manuela Battaglia; Rosa Bacchetta; Katharina Fleischhauer; Megan K Levings
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

7.  Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance.

Authors:  Manuela Battaglia; Angela Stabilini; Elena Draghici; Silvia Gregori; Cristina Mocchetti; Ezio Bonifacio; Maria-Grazia Roncarolo
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

8.  Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.

Authors:  Attilio Bondanza; Veronica Valtolina; Zulma Magnani; Maurilio Ponzoni; Katharina Fleischhauer; Mark Bonyhadi; Catia Traversari; Francesca Sanvito; Salvatore Toma; Marina Radrizzani; Simona La Seta-Catamancio; Fabio Ciceri; Claudio Bordignon; Chiara Bonini
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

9.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

10.  Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells.

Authors:  Megan K Levings; Silvia Gregori; Eleonora Tresoldi; Sabrina Cazzaniga; Chiara Bonini; Maria Grazia Roncarolo
Journal:  Blood       Date:  2004-10-12       Impact factor: 22.113

View more
  33 in total

Review 1.  T helper cytokines in dry eye disease.

Authors:  Stephen C Pflugfelder; Rosa M Corrales; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2013-09-04       Impact factor: 3.467

Review 2.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance.

Authors:  Hanyu Zeng; Rong Zhang; Boquan Jin; Lihua Chen
Journal:  Cell Mol Immunol       Date:  2015-06-08       Impact factor: 11.530

3.  Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development.

Authors:  Hua Yu; Nicola Gagliani; Harumichi Ishigame; Samuel Huber; Shu Zhu; Enric Esplugues; Kevan C Herold; Li Wen; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

4.  Protein tyrosine phosphatase PTPN22 has dual roles in promoting pathogen versus homeostatic-driven CD8 T-cell responses.

Authors:  Tatiana Jofra; Roberta Di Fonte; Tarun Edgar Hutchinson; Farhad Dastmalchi; Giuseppe Galvani; Manuela Battaglia; Shahram Salek-Ardakani; Georgia Fousteri
Journal:  Immunol Cell Biol       Date:  2016-10-11       Impact factor: 5.126

Review 5.  Biologia Futura: Emerging antigen-specific therapies for autoimmune diseases.

Authors:  Gabriella Sármay
Journal:  Biol Futur       Date:  2021-02-04

6.  Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy.

Authors:  Jeffrey Mao-Hwa Liu; Ping Chen; Molly Javier Uyeda; Brandon Cieniewicz; Ece Canan Sayitoglu; Benjamin Craig Thomas; Yohei Sato; Rosa Bacchetta; Alma-Martina Cepika; Maria Grazia Roncarolo
Journal:  Cytotherapy       Date:  2021-08-15       Impact factor: 5.414

Review 7.  Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

Authors:  O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

Review 8.  Regulatory T cells and their roles in immune dysregulation and allergy.

Authors:  Laurence Pellerin; Jennifer A Jenks; Philippe Bégin; Rosa Bacchetta; Kari C Nadeau
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy.

Authors:  Giada Amodio; Alessandra Mugione; Ana Maria Sanchez; Paola Viganò; Massimo Candiani; Edgardo Somigliana; Maria Grazia Roncarolo; Paola Panina-Bordignon; Silvia Gregori
Journal:  Hum Immunol       Date:  2012-12-10       Impact factor: 2.850

Review 10.  The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.

Authors:  Ece Canan Sayitoglu; Robert Arthur Freeborn; Maria Grazia Roncarolo
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.